Profilo
Kevin N.
Heller worked as Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He served as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
He was Chief Medical Officer at NextCure, Inc. from 2018 to 2020.
He held the position of Executive Vice President-Research & Development at Jasper Therapeutics, Inc. from 2021 to 2022.
Dr. Heller earned a doctorate from George Washington University and completed undergraduate studies at Yale University.
Precedenti posizioni note di Kevin Heller
| Società | Posizione | Fine |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/03/2022 |
| NEXTCURE, INC. | Direttore Tecnico/Scientifico/R&S | 04/08/2020 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/04/2018 |
| ASTRAZENECA PLC | Direttore Tecnico/Scientifico/R&S | 01/05/2015 |
Formazione di Kevin Heller
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
















